adrenalectomy alternative

Cytadren, or aminoglutethimide, is primarily used to treat Cushing’s syndrome and hormone-dependent cancers like breast and prostate cancer. It works by inhibiting aromatase and blocking cholesterol conversion, reducing adrenal steroids production. Despite its effectiveness, Cytadren can cause side effects such as dizziness and gastrointestinal issues, thereby requiring careful medical supervision. Initially developed in the 1960s, it has been largely replaced by newer therapies.